Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer: A Nationwide Case–Control Study Based on the French National Health Data System (SNDS)

BACKGROUND: Only a few studies investigated the association between proton pump inhibitor (PPI) use and pancreatic cancer, with inconsistent results. Moreover, these studies had a number of methodologic limitations. Our objective was to assess this association in a nationwide case–control study. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassalle, Marion, Le Tri, Thien, Afchain, Pauline, Camus, Marine, Kirchgesner, Julien, Zureik, Mahmoud, Dray-Spira, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381101/
https://www.ncbi.nlm.nih.gov/pubmed/34937794
http://dx.doi.org/10.1158/1055-9965.EPI-21-0786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381101/
https://www.ncbi.nlm.nih.gov/pubmed/34937794
http://dx.doi.org/10.1158/1055-9965.EPI-21-0786

Ejemplares similares